Understanding how lens proteins prevent cataracts and maintain eye transparency
Official title: Mechanisms of structural plasticity, client interactions, and co-aggregation of the lens ⍺-crystallins
Funded at Oregon Health & Science University · NIH-10914127 · Data updated 2026-11-12
This study is looking at how certain proteins in your eye help keep your lens clear and prevent cataracts as you age, with the hope of finding new ways to treat or prevent these eye problems.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $40,805 |
| NIH project number | 5F31EY033226-03 |
| Project ID | NIH-10914127 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for cataracts or those experiencing early signs of lens opacity.
✕Less likely to help
Patients with advanced cataracts requiring surgical intervention may not benefit directly from this research.
What this research studies
This research investigates the role of specific proteins called ⍺-crystallins in maintaining the clarity of the eye lens and preventing cataracts. It focuses on how these proteins interact and change structure in response to age-related conditions, which can lead to lens opacities. By using advanced imaging techniques, the study aims to uncover the molecular mechanisms that allow ⍺-crystallins to function effectively as chaperones, preventing harmful protein aggregation. This knowledge could lead to new strategies for treating or preventing cataracts and related eye disorders.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for cataracts and potentially delay the onset of age-related blindness.
How similar studies have gone: Previous research has shown promise in understanding protein interactions in the eye, but this specific approach to studying ⍺-crystallins is relatively novel.
Where this research is happening
-
Oregon Health & Science University
Portland, United States Active
Researchers
- Principal investigator: Miller, Adam Phillip — Oregon Health & Science University
- Study coordinator: Miller, Adam Phillip
Related research
Other NIH-funded projects on the same topics.
-
Understanding how a protein affects nerve cell movement in Alzheimer's disease
This study is looking at how a protein called APP affects the growth and movement of nerve cells, which is important for understanding Alzheimer's disease, and it aims to find out how problems with this protein might lead to nerve cell damage.
-
Understanding how the bone marrow environment drives AML resistance
A large NIH-funded project at Oregon Health & Science University is studying how the body’s own cell surroundings help acute myeloid leukemia become resistant to treatment, with potential paths to better therapies for patients.
-
Improving Safety at Work with a Low-Resource mHealth Program in Malaysia (and beyond)
A low-cost mobile health program to improve safety culture in Malaysian workplaces, with plans to adapt the approach for U.S. workers in high-risk industries.
-
Oregon Healthy Workplace Initiative for Better Health
A multi-site effort aims to improve the health and safety of workers by coordinating research, tools, and interventions across workplaces.
-
Understanding how AML cells become resistant to therapy over time
This project looks at why acute myeloid leukemia stops responding to treatment and how to design better drug combinations to prevent relapse.
-
Mechanisms and Countermeasures for Ultra-Potent Synthetic Opioid Overdose
A small, focused NIH grant aims to understand why ultra-potent synthetic opioids cause severe overdose and to explore potential countermeasures to keep people safe.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.